IGBA Struggles To Find Data On Global Drug Shortages For WHO
IGBA Reports Inconsistent And Missing Data Related To Supply Chains For Key Drugs
Executive Summary
An IGBA research report suggests international health bodies lack an accurate picture of global essential medicines shortages due to issues with monitoring and recording.
You may also be interested in...
Industry Speaks Out On Global Antibiotics Shortages
Responding to shortages of antibiotics seen around the world, the IGBA has insisted that the generics industry is working to address spikes in demand and has set out a series of recommendations to mitigate the situation. Meanwhile, US association the AAM has countered suggestions that supply issues are due to a “broken generic drug market.”
Gloomy First Half Results For Mayne
Revenue falls 33% over the half year for the ailing Australian pharmaceutical as it pivots from generics to the branded market
Chemiphar Profit Slumps 82.5% In Q3
Plummeting sales and profit following government price regulations pushes Chemiphar to target international expansion